Iovance Biotherapeutics (IOVA) Other Accumulated Expenses (2012 - 2024)
Iovance Biotherapeutics (IOVA) posted quarterly Other Accumulated Expenses of $4.0 million for Q1 2024, down 7.25% year-over-year from $4.3 million in Q2 2023, and down 39.65% quarter-over-quarter from $6.6 million in Q4 2023.
Iovance Biotherapeutics (IOVA) Other Accumulated Expenses (2012 - 2024) Analysis & Trends
Iovance Biotherapeutics (IOVA) has reported Other Accumulated Expenses for 8 consecutive years, with $4.0 million the latest figure, recorded in Q1 2024.
- In Q1 2024, Other Accumulated Expenses fell 7.25% year-over-year to $4.0 million; the TTM figure through Mar 2024 stood at $4.0 million (down 7.25% YoY), while the FY2023 annual figure was $6.6 million, up 99.61% from the prior year.
- Other Accumulated Expenses declined to $4.0 million in Q1 2024 per IOVA's latest filing, from $6.6 million in the prior quarter.
- Across five years, Other Accumulated Expenses topped out at $6.6 million in Q4 2023 and bottomed at $1.7 million in Q1 2020.
- Historically, Other Accumulated Expenses has averaged $3.3 million across 5 years, with a median of $3.3 million in 2022.
- Annual changes were most pronounced in 2022 — Other Accumulated Expenses surged 128.64% — and 2023, when it decreased 20.78%.
- Iovance Biotherapeutics' Other Accumulated Expenses stood at $1.7 million in 2020, then surged by 119.39% to $3.8 million in 2021, then dropped by 12.06% to $3.3 million in 2022, then jumped by 99.61% to $6.6 million in 2023, then tumbled by 39.65% to $4.0 million in 2024.
- Business Quant data shows IOVA's Other Accumulated Expenses at $4.0 million in Q1 2024, $6.6 million in Q4 2023, and $4.3 million in Q3 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Iovance Biotherapeutics | 3.16 Bn | 2.86 Bn | 55.72 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | 3.98 Mn |
| Dec 31, 2023 | 6.59 Mn |
| Sep 30, 2023 | 4.28 Mn |
| Jun 30, 2023 | 4.57 Mn |
| Mar 31, 2023 | 4.29 Mn |
| Dec 31, 2022 | 3.30 Mn |
| Sep 30, 2022 | 5.41 Mn |
| Jun 30, 2022 | 3.57 Mn |
| Mar 31, 2022 | 2.77 Mn |
| Dec 31, 2021 | 3.76 Mn |
| Sep 30, 2021 | 2.36 Mn |
| Jun 30, 2021 | 1.79 Mn |
| Mar 31, 2021 | 1.72 Mn |
| Dec 31, 2020 | 1.71 Mn |
| Sep 30, 2020 | 2.31 Mn |
| Jun 30, 2020 | 2.09 Mn |
| Mar 31, 2020 | 1.68 Mn |
| Dec 31, 2019 | 1.66 Mn |
| Sep 30, 2019 | 1.52 Mn |
| Jun 30, 2019 | 980,000.00 |